Enovis Corp. (ENOV)
27.68
+0.04
(+0.14%)
USD |
NYSE |
Nov 13, 16:00
27.65
-0.03
(-0.11%)
Pre-Market: 19:59
Enovis EPS Diluted (Quarterly) : 0.0537 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 0.0537 |
| June 30, 2026 | -0.0207 |
| March 31, 2026 | -0.1529 |
| December 31, 2025 | -9.074 |
| September 30, 2025 | -9.990 |
| June 30, 2025 | -0.643 |
| March 31, 2025 | -0.9855 |
| December 31, 2024 | -12.59 |
| September 30, 2024 | -0.5663 |
| June 30, 2024 | -0.3398 |
| March 31, 2024 | -1.317 |
| December 31, 2023 | 0.0543 |
| September 30, 2023 | -0.3372 |
| June 30, 2023 | -0.1834 |
| March 31, 2023 | -0.4298 |
| December 31, 2022 | -0.7119 |
| September 30, 2022 | -1.230 |
| June 30, 2022 | 1.410 |
| March 31, 2022 | 0.8391 |
| December 31, 2021 | -0.0366 |
| September 30, 2021 | 1.462 |
| June 30, 2021 | 1.675 |
| March 31, 2021 | 0.5433 |
| December 31, 2020 | 0.7774 |
| September 30, 2020 | 0.3053 |
| Date | Value |
|---|---|
| June 30, 2020 | -0.1859 |
| March 31, 2020 | 0.0984 |
| December 31, 2019 | -0.3676 |
| September 30, 2019 | 0.2293 |
| June 30, 2019 | -10.35 |
| March 31, 2019 | -1.167 |
| December 31, 2018 | 1.168 |
| September 30, 2018 | 0.793 |
| June 30, 2018 | 1.044 |
| March 31, 2018 | 0.5932 |
| December 31, 2017 | -7.132 |
| September 30, 2017 | 1.109 |
| June 30, 2017 | 1.292 |
| March 31, 2017 | 0.934 |
| December 31, 2016 | 0.9184 |
| September 30, 2016 | 0.6816 |
| June 30, 2016 | 0.9693 |
| March 31, 2016 | 0.5505 |
| December 31, 2015 | 1.068 |
| September 30, 2015 | 0.4405 |
| June 30, 2015 | 1.272 |
| March 31, 2015 | 1.248 |
| December 31, 2014 | 1.921 |
| September 30, 2014 | 1.756 |
| June 30, 2014 | 4.585 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Edwards Lifesciences Corp. | 0.5324 |
| Intuitive Surgical, Inc. | 1.487 |
| Kewaunee Scientific Corp. | 0.584 |
| STAAR Surgical Co. | 0.1084 |
| Stryker Corp. | 1.957 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 1.223M |
| Revenue (Quarterly) | 558.72M |
| Total Expenses (Quarterly) | 557.78M |
| Enterprise Value | 2.929B |
| Gross Profit Margin (Quarterly) | 53.08% |
| Profit Margin (Quarterly) | 0.22% |
| Earnings Yield | -33.21% |
| Operating Earnings Yield | 5.69% |
| Normalized Earnings Yield | -8.224 |